Global Gastrointestinal Therapeutics Market Research Report 2025(Status and Outlook)

March 2025 | 227 pages | ID: GC59B7B38E88EN
Bosson Research

Abstracts

Report Overview

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.

This report provides a deep insight into the global Gastrointestinal Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Therapeutics market in any manner.

Global Gastrointestinal Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AbbVie

Allergan

Johnson & Johnson

Takeda

Novartis

Pfizer

Merck

F. Hoffmann-La Roche

Eli Lilly

AstraZeneca

Procter & Gamble

Tillotts Pharma

Takeda

GlaxoSmithKline

Amgen

Market Segmentation (by Type)

Oral

Parenteral

Market Segmentation (by Application)

IBD

Irritable Bowel Syndrome (IBS)

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Gastrointestinal Therapeutics Market
• Overview of the regional outlook of the Gastrointestinal Therapeutics Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gastrointestinal Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Therapeutics Segment by Type
1.2.2 Gastrointestinal Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Gastrointestinal Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gastrointestinal Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Gastrointestinal Therapeutics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Therapeutics Product Life Cycle
3.3 Global Gastrointestinal Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Gastrointestinal Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Gastrointestinal Therapeutics Market Competitive Situation and Trends
3.8.1 Gastrointestinal Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Gastrointestinal Therapeutics Industry Chain Analysis
4.1 Gastrointestinal Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gastrointestinal Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Gastrointestinal Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 Global Gastrointestinal Therapeutics Market by Region
6.1 Global Gastrointestinal Therapeutics Market Size by Region
6.1.1 Global Gastrointestinal Therapeutics Market Size by Region
6.1.2 Global Gastrointestinal Therapeutics Market Size Market Share by Region
6.2 Global Gastrointestinal Therapeutics Sales by Region
6.2.1 Global Gastrointestinal Therapeutics Sales by Region
6.2.2 Global Gastrointestinal Therapeutics Sales Market Share by Region
7 North America Market Overview
7.1 North America Gastrointestinal Therapeutics Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Gastrointestinal Therapeutics Market Size by Type
7.3 North America Gastrointestinal Therapeutics Market Size by Application
8 Europe Market Overview
8.1 Europe Gastrointestinal Therapeutics Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Gastrointestinal Therapeutics Market Size by Type
8.3 Europe Gastrointestinal Therapeutics Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type
9.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application
10 South America Market Overview
10.1 South America Gastrointestinal Therapeutics Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Gastrointestinal Therapeutics Market Size by Type
10.3 South America Gastrointestinal Therapeutics Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Gastrointestinal Therapeutics Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Gastrointestinal Therapeutics Market Size by Type
11.3 Middle East and Africa Gastrointestinal Therapeutics Market Size by Application
12 Gastrointestinal Therapeutics Market Production by Region
12.1 Global Production of Gastrointestinal Therapeutics by Region(2020-2025)
12.2 Global Gastrointestinal Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global Gastrointestinal Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Gastrointestinal Therapeutics Production
12.4.1 North America Gastrointestinal Therapeutics Production Growth Rate (2020-2025)
12.4.2 North America Gastrointestinal Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Gastrointestinal Therapeutics Production
12.5.1 Europe Gastrointestinal Therapeutics Production Growth Rate (2020-2025)
12.5.2 Europe Gastrointestinal Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Gastrointestinal Therapeutics Production (2020-2025)
12.6.1 Japan Gastrointestinal Therapeutics Production Growth Rate (2020-2025)
12.6.2 Japan Gastrointestinal Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Gastrointestinal Therapeutics Production (2020-2025)
12.7.1 China Gastrointestinal Therapeutics Production Growth Rate (2020-2025)
12.7.2 China Gastrointestinal Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
13 Gastrointestinal Therapeutics Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Gastrointestinal Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global Gastrointestinal Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global Gastrointestinal Therapeutics Price by Type (2020-2033)
14 Gastrointestinal Therapeutics Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Gastrointestinal Therapeutics Market Sales by Application (2020-2033)
14.3 Global Gastrointestinal Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 AbbVie
15.1.1 AbbVie Basic Information
15.1.2 AbbVie Gastrointestinal Therapeutics Product Overview
15.1.3 AbbVie Gastrointestinal Therapeutics Product Market Performance
15.1.4 AbbVie Business Overview
15.1.5 AbbVie SWOT Analysis
15.1.6 AbbVie Recent Developments
15.2 Allergan
15.2.1 Allergan Basic Information
15.2.2 Allergan Gastrointestinal Therapeutics Product Overview
15.2.3 Allergan Gastrointestinal Therapeutics Product Market Performance
15.2.4 Allergan Business Overview
15.2.5 Allergan SWOT Analysis
15.2.6 Allergan Recent Developments
15.3 Johnson and Johnson
15.3.1 Johnson and Johnson Basic Information
15.3.2 Johnson and Johnson Gastrointestinal Therapeutics Product Overview
15.3.3 Johnson and Johnson Gastrointestinal Therapeutics Product Market Performance
15.3.4 Johnson and Johnson Business Overview
15.3.5 Johnson and Johnson SWOT Analysis
15.3.6 Johnson and Johnson Recent Developments
15.4 Takeda
15.4.1 Takeda Basic Information
15.4.2 Takeda Gastrointestinal Therapeutics Product Overview
15.4.3 Takeda Gastrointestinal Therapeutics Product Market Performance
15.4.4 Takeda Business Overview
15.4.5 Takeda Recent Developments
15.5 Novartis
15.5.1 Novartis Basic Information
15.5.2 Novartis Gastrointestinal Therapeutics Product Overview
15.5.3 Novartis Gastrointestinal Therapeutics Product Market Performance
15.5.4 Novartis Business Overview
15.5.5 Novartis Recent Developments
15.6 Pfizer
15.6.1 Pfizer Basic Information
15.6.2 Pfizer Gastrointestinal Therapeutics Product Overview
15.6.3 Pfizer Gastrointestinal Therapeutics Product Market Performance
15.6.4 Pfizer Business Overview
15.6.5 Pfizer Recent Developments
15.7 Merck
15.7.1 Merck Basic Information
15.7.2 Merck Gastrointestinal Therapeutics Product Overview
15.7.3 Merck Gastrointestinal Therapeutics Product Market Performance
15.7.4 Merck Business Overview
15.7.5 Merck Recent Developments
15.8 F. Hoffmann-La Roche
15.8.1 F. Hoffmann-La Roche Basic Information
15.8.2 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Overview
15.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Market Performance
15.8.4 F. Hoffmann-La Roche Business Overview
15.8.5 F. Hoffmann-La Roche Recent Developments
15.9 Eli Lilly
15.9.1 Eli Lilly Basic Information
15.9.2 Eli Lilly Gastrointestinal Therapeutics Product Overview
15.9.3 Eli Lilly Gastrointestinal Therapeutics Product Market Performance
15.9.4 Eli Lilly Business Overview
15.9.5 Eli Lilly Recent Developments
15.10 AstraZeneca
15.10.1 AstraZeneca Basic Information
15.10.2 AstraZeneca Gastrointestinal Therapeutics Product Overview
15.10.3 AstraZeneca Gastrointestinal Therapeutics Product Market Performance
15.10.4 AstraZeneca Business Overview
15.10.5 AstraZeneca Recent Developments
15.11 Procter and Gamble
15.11.1 Procter and Gamble Basic Information
15.11.2 Procter and Gamble Gastrointestinal Therapeutics Product Overview
15.11.3 Procter and Gamble Gastrointestinal Therapeutics Product Market Performance
15.11.4 Procter and Gamble Business Overview
15.11.5 Procter and Gamble Recent Developments
15.12 Tillotts Pharma
15.12.1 Tillotts Pharma Basic Information
15.12.2 Tillotts Pharma Gastrointestinal Therapeutics Product Overview
15.12.3 Tillotts Pharma Gastrointestinal Therapeutics Product Market Performance
15.12.4 Tillotts Pharma Business Overview
15.12.5 Tillotts Pharma Recent Developments
15.13 Takeda
15.13.1 Takeda Basic Information
15.13.2 Takeda Gastrointestinal Therapeutics Product Overview
15.13.3 Takeda Gastrointestinal Therapeutics Product Market Performance
15.13.4 Takeda Business Overview
15.13.5 Takeda Recent Developments
15.14 GlaxoSmithKline
15.14.1 GlaxoSmithKline Basic Information
15.14.2 GlaxoSmithKline Gastrointestinal Therapeutics Product Overview
15.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Product Market Performance
15.14.4 GlaxoSmithKline Business Overview
15.14.5 GlaxoSmithKline Recent Developments
15.15 Amgen
15.15.1 Amgen Basic Information
15.15.2 Amgen Gastrointestinal Therapeutics Product Overview
15.15.3 Amgen Gastrointestinal Therapeutics Product Market Performance
15.15.4 Amgen Business Overview
15.15.5 Amgen Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 4. Global Gastrointestinal Therapeutics Market Size by Application (M USD)
Table 5. Gastrointestinal Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2024)
Table 11. Global Market Gastrointestinal Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Gastrointestinal Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers Gastrointestinal Therapeutics Product Type
Table 14. Global Gastrointestinal Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Gastrointestinal Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global Gastrointestinal Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Gastrointestinal Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global Gastrointestinal Therapeutics Sales by Region (2020-2033) & (K Units)
Table 29. Global Gastrointestinal Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America Gastrointestinal Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Gastrointestinal Therapeutics Sales by Country (2020-2033) & (K Units)
Table 32. North America Gastrointestinal Therapeutics Sales by Type (K Units)
Table 33. North America Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 34. North America Gastrointestinal Therapeutics Sales (K Units) by Type (2020-2033)
Table 35. North America Gastrointestinal Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America Gastrointestinal Therapeutics Sales by Application (K Units)
Table 37. North America Gastrointestinal Therapeutics Market Size by Application (M USD)
Table 38. North America Gastrointestinal Therapeutics Sales (K Units) by Application (2020-2033)
Table 39. North America Gastrointestinal Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Gastrointestinal Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Gastrointestinal Therapeutics Sales by Country (2020-2033) & (K Units)
Table 42. Europe Gastrointestinal Therapeutics Sales by Type (K Units)
Table 43. Europe Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 44. Europe Gastrointestinal Therapeutics Sales (K Units) by Type (2020-2033)
Table 45. Europe Gastrointestinal Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Gastrointestinal Therapeutics Sales by Application (K Units)
Table 47. Europe Gastrointestinal Therapeutics Market Size by Application (M USD)
Table 48. Europe Gastrointestinal Therapeutics Sales (K Units) by Application (2020-2033)
Table 49. Europe Gastrointestinal Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Gastrointestinal Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Gastrointestinal Therapeutics Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Gastrointestinal Therapeutics Sales by Type (K Units)
Table 53. Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific Gastrointestinal Therapeutics Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Gastrointestinal Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Gastrointestinal Therapeutics Sales by Application (K Units)
Table 57. Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific Gastrointestinal Therapeutics Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Gastrointestinal Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America Gastrointestinal Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Gastrointestinal Therapeutics Sales by Country (2020-2033) & (K Units)
Table 62. South America Gastrointestinal Therapeutics Sales by Type (K Units)
Table 63. South America Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 64. South America Gastrointestinal Therapeutics Sales (K Units) by Type (2020-2033)
Table 65. South America Gastrointestinal Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America Gastrointestinal Therapeutics Sales by Application (K Units)
Table 67. South America Gastrointestinal Therapeutics Market Size by Application (M USD)
Table 68. South America Gastrointestinal Therapeutics Sales (K Units) by Application (2020-2033)
Table 69. South America Gastrointestinal Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Gastrointestinal Therapeutics Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Gastrointestinal Therapeutics Sales by Type (K Units)
Table 73. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa Gastrointestinal Therapeutics Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Gastrointestinal Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Gastrointestinal Therapeutics Sales by Application (K Units)
Table 77. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa Gastrointestinal Therapeutics Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Gastrointestinal Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global Gastrointestinal Therapeutics Production (K Units) by Region(2020-2025)
Table 81. Global Gastrointestinal Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Gastrointestinal Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global Gastrointestinal Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Gastrointestinal Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Gastrointestinal Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Gastrointestinal Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Gastrointestinal Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Gastrointestinal Therapeutics Sales by Type (K Units)
Table 89. Global Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 90. Global Gastrointestinal Therapeutics Sales (K Units) by Type (2020-2033)
Table 91. Global Gastrointestinal Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global Gastrointestinal Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global Gastrointestinal Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global Gastrointestinal Therapeutics Sales (K Units) by Application
Table 95. Global Gastrointestinal Therapeutics Market Size by Application(M USD)
Table 96. Global Gastrointestinal Therapeutics Sales by Application (2020-2033) & (K Units)
Table 97. Global Gastrointestinal Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global Gastrointestinal Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Gastrointestinal Therapeutics Market Share by Application (2020-2033)
Table 100. Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. AbbVie Basic Information
Table 102. AbbVie Gastrointestinal Therapeutics Product Overview
Table 103. AbbVie Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. AbbVie Business Overview
Table 105. AbbVie SWOT Analysis
Table 106. AbbVie Recent Developments
Table 107. Allergan Basic Information
Table 108. Allergan Gastrointestinal Therapeutics Product Overview
Table 109. Allergan Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Allergan Business Overview
Table 111. Allergan SWOT Analysis
Table 112. Allergan Recent Developments
Table 113. Johnson and Johnson Basic Information
Table 114. Johnson and Johnson Gastrointestinal Therapeutics Product Overview
Table 115. Johnson and Johnson Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Johnson and Johnson Business Overview
Table 117. Johnson and Johnson SWOT Analysis
Table 118. Johnson and Johnson Recent Developments
Table 119. Takeda Basic Information
Table 120. Takeda Gastrointestinal Therapeutics Product Overview
Table 121. Takeda Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Takeda Business Overview
Table 123. Takeda Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Gastrointestinal Therapeutics Product Overview
Table 126. Novartis Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Pfizer Basic Information
Table 130. Pfizer Gastrointestinal Therapeutics Product Overview
Table 131. Pfizer Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Pfizer Business Overview
Table 133. Pfizer Recent Developments
Table 134. Merck Basic Information
Table 135. Merck Gastrointestinal Therapeutics Product Overview
Table 136. Merck Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Merck Business Overview
Table 138. Merck Recent Developments
Table 139. F. Hoffmann-La Roche Basic Information
Table 140. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Overview
Table 141. F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. F. Hoffmann-La Roche Business Overview
Table 143. F. Hoffmann-La Roche Recent Developments
Table 144. Eli Lilly Basic Information
Table 145. Eli Lilly Gastrointestinal Therapeutics Product Overview
Table 146. Eli Lilly Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Eli Lilly Business Overview
Table 148. Eli Lilly Recent Developments
Table 149. AstraZeneca Basic Information
Table 150. AstraZeneca Gastrointestinal Therapeutics Product Overview
Table 151. AstraZeneca Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. AstraZeneca Business Overview
Table 153. AstraZeneca Recent Developments
Table 154. Procter and Gamble Basic Information
Table 155. Procter and Gamble Gastrointestinal Therapeutics Product Overview
Table 156. Procter and Gamble Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Procter and Gamble Business Overview
Table 158. Procter and Gamble Recent Developments
Table 159. Tillotts Pharma Basic Information
Table 160. Tillotts Pharma Gastrointestinal Therapeutics Product Overview
Table 161. Tillotts Pharma Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Tillotts Pharma Business Overview
Table 163. Tillotts Pharma Recent Developments
Table 164. Takeda Basic Information
Table 165. Takeda Gastrointestinal Therapeutics Product Overview
Table 166. Takeda Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Takeda Business Overview
Table 168. Takeda Recent Developments
Table 169. GlaxoSmithKline Basic Information
Table 170. GlaxoSmithKline Gastrointestinal Therapeutics Product Overview
Table 171. GlaxoSmithKline Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. GlaxoSmithKline Business Overview
Table 173. GlaxoSmithKline Recent Developments
Table 174. Amgen Basic Information
Table 175. Amgen Gastrointestinal Therapeutics Product Overview
Table 176. Amgen Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Amgen Business Overview
Table 178. Amgen Recent Developments
List of Figures
Figure 1. Product Picture of Gastrointestinal Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Gastrointestinal Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Gastrointestinal Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Therapeutics Product Life Cycle
Figure 13. Gastrointestinal Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Gastrointestinal Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gastrointestinal Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Gastrointestinal Therapeutics
Figure 19. Global Gastrointestinal Therapeutics Market PEST Analysis
Figure 20. Global Gastrointestinal Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Gastrointestinal Therapeutics Market Size by Region
Figure 27. Global Gastrointestinal Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global Gastrointestinal Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Gastrointestinal Therapeutics Market Size (M USD) by Country
Figure 33. USA Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Gastrointestinal Therapeutics Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Gastrointestinal Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Gastrointestinal Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Gastrointestinal Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Gastrointestinal Therapeutics Market Size (M USD)by Type
Figure 40. North America Gastrointestinal Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Gastrointestinal Therapeutics Market Size (M USD) by Country
Figure 45. Germany Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Gastrointestinal Therapeutics Market Size (M USD) by Type
Figure 56. Europe Gastrointestinal Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Gastrointestinal Therapeutics Market Size (M USD) by Country
Figure 61. China Gastrointestinal Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Gastrointestinal Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Gastrointestinal Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Gastrointestinal Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Gastrointestinal Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Gastrointestinal Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific Gastrointestinal Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Gastrointestinal Therapeutics Market Size (M USD) by Country
Figure 77. Brazil Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Gastrointestinal Therapeutics Market Size (M USD) by Type
Figure 84. South America Gastrointestinal Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Gastrointestinal Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Gastrointestinal Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Gastrointestinal Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa Gastrointestinal Therapeutics Market Size (M USD) by Application
Figure 101. Global Gastrointestinal Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America Gastrointestinal Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Gastrointestinal Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Gastrointestinal Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. China Gastrointestinal Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Gastrointestinal Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of Gastrointestinal Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of Gastrointestinal Therapeutics by Type in 2024
Figure 110. Market Size Share of Gastrointestinal Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of Gastrointestinal Therapeutics by Type in 2024
Figure 112. Global Gastrointestinal Therapeutics Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Gastrointestinal Therapeutics Market Size by Application(M USD)
Figure 115. Global Gastrointestinal Therapeutics Market Share by Application
Figure 116. Global Gastrointestinal Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global Gastrointestinal Therapeutics Sales Market Share by Application in 2024
Figure 118. Global Gastrointestinal Therapeutics Market Share by Application (2020-2033)
Figure 119. Global Gastrointestinal Therapeutics Market Share by Application in 2024
Figure 120. Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2020-2033)